Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3022% below fair value
$75.56−1.52 (-1.97%)
Close on Nov 20, 2026Market cap $1.86BP/E –Yield 2.26%
Innospec gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Innospec's gross profit for the twelve months ending Jun 30, 2026 was $505.90M, down 0.5% year over year. For fiscal 2025 it was $492.40M, down 9.3% from the year before. Over ten years it grew 3.6% a year on average. The highest annual figure on record is $591.10M in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $492.40M | -9.3% |
| FY2024 | Dec 31, 2024 | $542.90M | -8.2% |
| FY2023 | Dec 31, 2023 | $591.10M | +0.7% |
| FY2022 | Dec 31, 2022 | $586.70M | +34.9% |
| FY2021 | Dec 31, 2021 | $434.90M | +26.9% |
| FY2020 | Dec 31, 2020 | $342.70M | -26.5% |
| FY2019 | Dec 31, 2019 | $466.20M | +7.2% |
| FY2018 | Dec 31, 2018 | $435.00M | +7.9% |
| FY2017 | Dec 31, 2017 | $403.30M | +21.4% |
| FY2016 | Dec 31, 2016 | $332.30M | -4.0% |
| FY2015 | Dec 31, 2015 | $346.00M | +14.6% |
| FY2014 | Dec 31, 2014 | $302.00M | +18.3% |
| FY2013 | Dec 31, 2013 | $255.20M | +8.0% |
| FY2012 | Dec 31, 2012 | $236.40M | +4.4% |
| FY2011 | Dec 31, 2011 | $226.40M | +5.7% |
| FY2010 | Dec 31, 2010 | $214.10M | +15.0% |
| FY2009 | Dec 31, 2009 | $186.20M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $138.30M | +12.3% |
| Q1 FY2026 | Mar 31, 2026 | $123.50M | -1.3% |
| Q4 FY2025 | Dec 31, 2025 | $127.40M | -6.5% |
| Q3 FY2025 | Sep 30, 2025 | $116.70M | -6.0% |
| Q2 FY2025 | Jun 30, 2025 | $123.20M | -2.9% |
| Q1 FY2025 | Mar 31, 2025 | $125.10M | -19.7% |
| Q4 FY2024 | Dec 31, 2024 | $136.20M | -12.5% |
| Q3 FY2024 | Sep 30, 2024 | $124.10M | -9.5% |
| Q2 FY2024 | Jun 30, 2024 | $126.90M | -15.6% |
| Q1 FY2024 | Mar 31, 2024 | $155.70M | +5.3% |
| Q4 FY2023 | Dec 31, 2023 | $155.70M | +2.7% |
| Q3 FY2023 | Sep 30, 2023 | $137.20M | -12.1% |
| Q2 FY2023 | Jun 30, 2023 | $150.40M | +7.6% |
| Q1 FY2023 | Mar 31, 2023 | $147.80M | +6.1% |
| Q4 FY2022 | Dec 31, 2022 | $151.60M | +34.3% |
| Q3 FY2022 | Sep 30, 2022 | $156.00M | +38.2% |
| Q2 FY2022 | Jun 30, 2022 | $139.80M | +29.1% |
| Q1 FY2022 | Mar 31, 2022 | $139.30M | +38.2% |
| Q4 FY2021 | Dec 31, 2021 | $112.90M | +24.1% |
| Q3 FY2021 | Sep 30, 2021 | $112.90M | +43.5% |
| Q2 FY2021 | Jun 30, 2021 | $108.30M | +83.2% |
| Q1 FY2021 | Mar 31, 2021 | $100.80M | -11.5% |
| Q4 FY2020 | Dec 31, 2020 | $91.00M | -23.0% |
| Q3 FY2020 | Sep 30, 2020 | $78.70M | -33.9% |
| Q2 FY2020 | Jun 30, 2020 | $59.10M | -46.8% |
| Q1 FY2020 | Mar 31, 2020 | $113.90M | -3.3% |
| Q4 FY2019 | Dec 31, 2019 | $118.20M | +1.3% |
| Q3 FY2019 | Sep 30, 2019 | $119.10M | +7.3% |
| Q2 FY2019 | Jun 30, 2019 | $111.10M | +8.1% |
| Q1 FY2019 | Mar 31, 2019 | $117.80M | +12.7% |
| Q4 FY2018 | Dec 31, 2018 | $116.70M | +7.6% |
| Q3 FY2018 | Sep 30, 2018 | $111.00M | +12.3% |
| Q2 FY2018 | Jun 30, 2018 | $102.80M | -2.2% |
| Q1 FY2018 | Mar 31, 2018 | $104.50M | +15.0% |
| Q4 FY2017 | Dec 31, 2017 | $108.50M | +18.7% |
| Q3 FY2017 | Sep 30, 2017 | $98.80M | +24.7% |
| Q2 FY2017 | Jun 30, 2017 | $105.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $90.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $91.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $79.20M | – |
See a number that looks wrong?